Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue.

Saved in:

Bibliographic Details
Title:	Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue.
Authors:	Brandi G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy., Deiana C; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy., Galvani L; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy., Palloni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Ricci AD; Medical Oncology Unit, National Institute of Gastroenterology, 'Saverio de Bellis' Research Hospital, Bari, Italy., Rizzo A; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', Bari, Italy., Tavolari S; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy.
Source:	Frontiers in oncology [Front Oncol] 2023 Apr 24; Vol. 13, pp. 1137510. Date of Electronic Publication: 2023 Apr 24 (Print Publication: 2023).
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2234-943X
DOI:	10.3389/fonc.2023.1137510